Eric L. Garland, PhD, LCSW, is Distinguished Endowed Chair in Research, Distinguished Professor, and Associate Dean for Research at the University of Utah College of Social Work, where he is also Director of the Center on Mindfulness and Integrative Health Intervention Development. Dr. Garland is the developer of Mindfulness-Oriented Recovery Enhancement. He has published more than 250 scientific papers and has conducted extensive clinical trials of mindfulness for addiction and chronic pain. Dr. Garland is an appointed member of the Multi-Disciplinary Working Group that assists the Helping to End Addiction Long-term Initiative of the National Institutes of Health (NIH HEAL Initiative). In 2021, a bibliometric analysis of mindfulness research published over the past 55 years found Dr. Garland to be the most prolific author of mindfulness research in the world.
"""This book will appeal to pain specialists, because Garland--a pioneer in mindfulness-based treatments for pain--is both a scientist and a practitioner. He provides novel scientific insights into how MORE works for patients taking opioids in the context of persistent pain. The book will be of particular interest to clinicians struggling to engage chronic pain patients in meditation or other nonpharmacologic treatments. It is loaded with clinical tips on how to tailor treatment rationales and procedures for patients who vary with regard to their current opioid use, risk factors, or active misuse or addiction. This book is a remarkable resource for any clinician who works with patients suffering from persistent pain or wishes to learn more about the scientific basis of mindfulness-based pain relief.""--Francis J. Keefe, PhD, Professor of Psychiatry and Director, Duke Pain Prevention and Treatment Research Program, Duke University School of Medicine ""Guided by neuroscience and rooted in contemplative science, Garland's analysis of the common mechanisms underlying opioid use and chronic pain is incisive and generative. MORE opens doors to recovery for sufferers whose clinical care has been fragmented and siloed. This accessible treatment manual is backed by 15 years of validation and never takes its focus off the people it is intended to serve. MORE is destined to become the new standard of care for a largely underserved population.""--Zindel Segal, PhD, Distinguished Professor of Psychology in Mood Disorders, University of Toronto-Scarborough, Canada"